These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15604962)

  • 21. (18)F FDOPA uptake in brain metastasis of breast cancer.
    Chiaravalloti A; Floris R; Schillaci O
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):46-7. PubMed ID: 26117270
    [No Abstract]   [Full Text] [Related]  

  • 22. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Added Diagnostic Value of
    Addeo P; Poncet G; Goichot B; Leclerc L; Brigand C; Mutter D; Romain B; Namer IJ; Bachellier P; Imperiale A
    J Gastrointest Surg; 2018 Apr; 22(4):722-730. PubMed ID: 29235002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy.
    Chen W; Silverman DH; Delaloye S; Czernin J; Kamdar N; Pope W; Satyamurthy N; Schiepers C; Cloughesy T
    J Nucl Med; 2006 Jun; 47(6):904-11. PubMed ID: 16741298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visualisation of impaired dopamine biosynthesis in a case of aromatic L-amino acid decarboxylase deficiency by co-registered 18F-FDOPA PET and magnetic resonance imaging.
    Hsieh HJ; Lin SH; Liu HM
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):517. PubMed ID: 15821966
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dual time point 18F-FDOPA PET as a tool for characterizing brain tumors].
    González-Forero M; Prieto E; Domínguez I; Vigil C; Peñuelas I; Arbizu J
    Rev Esp Med Nucl; 2011; 30(2):88-93. PubMed ID: 21334774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
    Archier A; Varoquaux A; Garrigue P; Montava M; Guerin C; Gabriel S; Beschmout E; Morange I; Fakhry N; Castinetti F; Sebag F; Barlier A; Loundou A; Guillet B; Pacak K; Taïeb D
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1248-57. PubMed ID: 26637204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.
    Magnaldi S; Mayerhoefer ME; Khameneh A; Schuetz M; Javor D; Mitterhauser M; Dudczak R; Hacker M; Karanikas G
    Anticancer Res; 2014 Feb; 34(2):791-5. PubMed ID: 24511014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas.
    Tripathi M; Sharma R; D'Souza M; Jaimini A; Panwar P; Varshney R; Datta A; Kumar N; Garg G; Singh D; Grover RK; Mishra AK; Mondal A
    Clin Nucl Med; 2009 Dec; 34(12):878-83. PubMed ID: 20139821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.
    Krämer SD; Mu L; Müller A; Keller C; Kuznetsova OF; Schweinsberg C; Franck D; Müller C; Ross TL; Schibli R; Ametamey SM
    J Nucl Med; 2012 Mar; 53(3):434-42. PubMed ID: 22331220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of kinetic macro parameters to changes in dopamine synthesis, storage, and metabolism: a simulation study for [¹⁸F]FDOPA PET by a model with detailed dopamine pathway.
    Matsubara K; Watabe H; Kumakura Y; Hayashi T; Endres CJ; Minato K; Iida H
    Synapse; 2011 Aug; 65(8):751-62. PubMed ID: 21190220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated [(18)F]FDOPA utilization in the periaqueductal gray and medial nucleus accumbens of patients with early Parkinson's disease.
    Kumakura Y; Danielsen EH; Gjedde A; Vernaleken I; Buchholz HG; Heinz A; Gründer G; Bartenstein P; Cumming P
    Neuroimage; 2010 Feb; 49(4):2933-9. PubMed ID: 19941962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
    Ledezma CJ; Chen W; Sai V; Freitas B; Cloughesy T; Czernin J; Pope W
    Eur J Radiol; 2009 Aug; 71(2):242-8. PubMed ID: 18511228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Image in endocrinology. Localization of an adrenocorticotropin-producing pheochromocytoma using 18F-dihydroxyphenylalanine positron emission tomography.
    Fiebrich HB; Brouwers AH; van Bergeijk L; van den Berg G
    J Clin Endocrinol Metab; 2009 Mar; 94(3):748-9. PubMed ID: 19261897
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiparametric evaluation of low grade gliomas at follow-up: comparison between diffusion and perfusion MR with (18)F-FDOPA PET.
    Rossi Espagnet MC; Romano A; Mancuso V; Cicone F; Napolitano A; Scaringi C; Minniti G; Bozzao A
    Br J Radiol; 2016 Oct; 89(1066):20160476. PubMed ID: 27505026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. F-18 FDG and F-18 FDOPA PET brain imaging in subacute sclerosing panencephalitis.
    Hsieh HJ; Lin SH; Chu YK; Chang CP; Wang SJ
    Clin Nucl Med; 2005 Jul; 30(7):519-20. PubMed ID: 15965337
    [No Abstract]   [Full Text] [Related]  

  • 37. 18F-FDOPA PET/CT imaging of insulinoma revisited.
    Imperiale A; Sebag F; Vix M; Castinetti F; Kessler L; Moreau F; Bachellier P; Guillet B; Namer IJ; Mundler O; Taïeb D
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):409-18. PubMed ID: 25367749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [6-[F18]-fluoro-dihydroxyphenylalanine positron emission tomography for diagnosis of pheochromocytoma].
    Ramós-Leví AM; Molino A; Ochagavía S; Díaz Pérez A
    Endocrinol Nutr; 2013; 60(6):336-8. PubMed ID: 23333636
    [No Abstract]   [Full Text] [Related]  

  • 39. Simultaneous (18)F-FDOPA PET/CT-guided biopsy and radiofrequency ablation of recurrent neuroendocrine hepatic metastasis: further step toward a theranostic approach.
    Imperiale A; Garnon J; Bachellier P; Gangi A; Namer IJ
    Clin Nucl Med; 2015 Jun; 40(6):e334-5. PubMed ID: 25706791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
    Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS
    J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.